TearLab (OTCMKTS:TEAR) Releases Quarterly Earnings Results

TearLab (OTCMKTS:TEAR) (TSE:TLB) posted its quarterly earnings data on Friday. The medical research company reported ($0.12) earnings per share for the quarter, reports. The firm had revenue of $5.09 million during the quarter.

TEAR stock opened at $0.06 on Friday. TearLab has a twelve month low of $0.02 and a twelve month high of $0.22. The business has a 50 day simple moving average of $0.06 and a 200-day simple moving average of $0.04.

TearLab Company Profile

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

Featured Story: The Structure of a Futures Contract

Earnings History for TearLab (OTCMKTS:TEAR)

Receive News & Ratings for TearLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab and related companies with MarketBeat.com's FREE daily email newsletter.